BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 34919190)

  • 1. Recent update on the heterogeneity of the Alzheimer's disease spectrum.
    Jellinger KA
    J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathological assessment of the Alzheimer spectrum.
    Jellinger KA
    J Neural Transm (Vienna); 2020 Sep; 127(9):1229-1256. PubMed ID: 32740684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology of the Alzheimer's continuum: an update.
    Jellinger KA
    Free Neuropathol; 2020 Jan; 1():. PubMed ID: 37283686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathobiological Subtypes of Alzheimer Disease.
    Jellinger KA
    Dement Geriatr Cogn Disord; 2020; 49(4):321-333. PubMed ID: 33429401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathology of Alzheimer's Disease.
    Trejo-Lopez JA; Yachnis AT; Prokop S
    Neurotherapeutics; 2022 Jan; 19(1):173-185. PubMed ID: 34729690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia.
    Janocko NJ; Brodersen KA; Soto-Ortolaza AI; Ross OA; Liesinger AM; Duara R; Graff-Radford NR; Dickson DW; Murray ME
    Acta Neuropathol; 2012 Nov; 124(5):681-92. PubMed ID: 22968369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prominent amyloid plaque pathology and cerebral amyloid angiopathy in APP V717I (London) carrier - phenotypic variability in autosomal dominant Alzheimer's disease.
    Lloyd GM; Trejo-Lopez JA; Xia Y; McFarland KN; Lincoln SJ; Ertekin-Taner N; Giasson BI; Yachnis AT; Prokop S
    Acta Neuropathol Commun; 2020 Mar; 8(1):31. PubMed ID: 32164763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study.
    Murray ME; Graff-Radford NR; Ross OA; Petersen RC; Duara R; Dickson DW
    Lancet Neurol; 2011 Sep; 10(9):785-96. PubMed ID: 21802369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline.
    Rabin JS; Nichols E; La Joie R; Casaletto KB; Palta P; Dams-O'Connor K; Kumar RG; George KM; Satizabal CL; Schneider JA; Pa J; Brickman AM
    Brain; 2022 Aug; 145(8):2823-2833. PubMed ID: 35759327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series.
    Kovacs GG; Milenkovic I; Wöhrer A; Höftberger R; Gelpi E; Haberler C; Hönigschnabl S; Reiner-Concin A; Heinzl H; Jungwirth S; Krampla W; Fischer P; Budka H
    Acta Neuropathol; 2013 Sep; 126(3):365-84. PubMed ID: 23900711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16 years of memory loss.
    Carlos AF; Koga S; Graff-Radford NR; Baker MC; Rademakers R; Ross OA; Dickson DW; Josephs KA
    Neuropathology; 2024 Apr; 44(2):115-125. PubMed ID: 37525358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological heterogeneity of Alzheimer's disease with pure Alzheimer's disease pathology: Cases associated with dementia with Lewy bodies, very early-onset dementia, and primary progressive aphasia.
    Kawakatsu S; Kobayashi R; Hayashi H; Morioka D; Utsunomiya A; Kabasawa T; Ohe R; Otani K
    Neuropathology; 2021 Dec; 41(6):427-449. PubMed ID: 34816507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of APOE on amyloid and tau accumulation in argyrophilic grain disease and Alzheimer's disease.
    Raulin AC; Doss SV; Heckman MG; Craver EC; Li Z; Ikezu TC; Sekiya H; Liu CC; Martens YA; Rosenberg CL; Kuchenbecker LA; DeTure M; Reichard RR; Nguyen AT; Constantopoulos E; Larsen RA; Kounaves EK; Murray ME; Dickson DW; Petersen RC; Bu G; Kanekiyo T
    Acta Neuropathol Commun; 2024 Feb; 12(1):25. PubMed ID: 38336940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
    Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
    Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease.
    Boon BDC; Hoozemans JJM; Lopuhaä B; Eigenhuis KN; Scheltens P; Kamphorst W; Rozemuller AJM; Bouwman FH
    J Neuroinflammation; 2018 May; 15(1):170. PubMed ID: 29843759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities.
    Katsumata Y; Shade LM; Hohman TJ; Schneider JA; Bennett DA; Farfel JM; ; Kukull WA; Fardo DW; Nelson PT
    Neurobiol Dis; 2022 Nov; 174():105880. PubMed ID: 36191742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles.
    Sánchez-Juan P; Valeriano-Lorenzo E; Ruiz-González A; Pastor AB; Rodrigo Lara H; López-González F; Zea-Sevilla MA; Valentí M; Frades B; Ruiz P; Saiz L; Burgueño-García I; Calero M; Del Ser T; Rábano A
    Brain; 2024 May; 147(5):1667-1679. PubMed ID: 38634687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.